Vuzix Corporation — Q2 2022 Form 10-Q
Reporting period: Three and six months ended June 30, 2022. Vuzix designs, manufactures, markets and sells smart glasses and augmented-reality display products, and provides engineering services. 2021 comparative results were restated for stock-based compensation associated with the company’s long-term incentive plan.
Financial performance and position
| Metric | Q2 2022 | Q2 2021 | Six months 2022 | Six months 2021 |
|---|---|---|---|---|
| Revenue | $3.01 million | $2.92 million | $5.51 million | $6.83 million |
| Gross profit | $426,000 | $579,000 | $1.07 million | $1.66 million |
| Gross margin | 14% | 20% | 19% | 24% |
| Operating loss | $10.00 million | $9.21 million | $20.41 million | $18.29 million |
| Net loss | $10.02 million | $9.25 million | $20.53 million | $18.40 million |
| Basic and diluted loss per share | $0.16 | $0.15 | $0.32 | $0.31 |
| Cash used in operating activities | — | $11.02 million | $13.11 million |
- Six-month product sales fell 19% to $5.40 million, primarily reflecting a 21% decline in smart-glasses revenue; engineering-services revenue fell 44% to $109,000. Q2 revenue rose 3% year over year, although smart-glasses sales were down 1%.
- Management attributed lower product margins to higher volume discounts, foreign-exchange effects on non-U.S.-dollar sales, and increased allocation of manufacturing overhead to product costs. Six-month product gross margin was 19%, versus 23% a year earlier.
- Six-month operating expenses rose 8% to $21.48 million. R&D increased 24% and selling and marketing increased 48%, while G&A decreased 7%. R&D growth included spending on next-generation Smart Glasses (Shield).
- Cash and cash equivalents were $100.58 million at June 30, down $19.62 million from year-end 2021. Current assets of $116.94 million exceeded current liabilities of $7.79 million; working capital was $109.15 million, down from $132.99 million at year-end.
- Six-month investing cash outflow was $8.40 million, including equipment and tooling expenditures and Atomistic-related payments. Financing cash outflow was $203,000; the prior-year period included substantial equity-offering and warrant-exercise proceeds.
- The company reported no conventional debt outstanding. Liabilities included $10.50 million of remaining Atomistic technology-license commitments, operating lease liabilities, and other current obligations. Total liabilities were $14.36 million.
Material developments, outlook and risks
- In May 2022, Vuzix entered agreements with Atomistic SAS for an exclusive mLED technology license and custom backplane-chip design, with total cash commitments of $30 million. The company recorded a $15 million license asset and liability, paid $4.5 million toward the license, and expected to pay the remaining $10.5 million over 18–24 months. About $11 million remained committed for backplane design and tooling, also expected to be funded over 18–24 months.
- Atomistic-related founder share purchases are contingent on milestones; the filing describes a minimum of 1.75 million and maximum of 2.84375 million Vuzix shares, as well as a contingent $2.5 million cash payment. None of the share commitments had been issued as of June 30.
- Vuzix repurchased 36,685 shares at an average $6.84 under a one-year program authorizing up to $25 million in buybacks. The program is discretionary and may be suspended or discontinued.
- Management expected to recognize $691,134 of remaining revenue on a waveguide development project before the end of 2022. This is a project-specific expectation, not company-wide revenue guidance; the filing provides no broader financial guidance.
- Management stated that cash requirements include operating losses, R&D, working capital, capital expenditures and licensing commitments, and identified cash as the principal liquidity source. The filing discusses sufficiency of cash for at least the next 12 months as a forward-looking matter, subject to risks.
- Customer concentration increased: one customer represented 45% of Q2 product revenue, and three customers represented 72% of accounts receivable at quarter-end. Management also cited longer component lead times, chip shortages, supply-chain exposure, foreign-exchange risk, competition, technological change and potentially delayed customer orders.
- Disclosure controls were deemed ineffective because of a previously identified material weakness in accounting for LTIP option fair value. Remediation procedures had been introduced, but management said there had not been enough time to complete testing; it expected full remediation during 2022.
- The company reported no current or pending material litigation. Q2 and six-month net losses were higher than the restated 2021 comparisons; the 2021 restatement increased net loss by $466,015 for Q2 and $2,978,022 for the first six months.
Key facts for investors to verify
- Whether revenue trends, smart-glasses demand and gross margins improve, given the first-half sales decline and Q2 margin compression.
- Actual cash burn, capital spending and ability to fund operating losses alongside the Atomistic license and backplane commitments.
- Atomistic milestone progress, remaining payments, contingent dilution and the timing and conditions for any share issuance.
- Customer concentration and the effects of component lead times, supply constraints, foreign exchange and order timing.
- Progress and testing evidence supporting management’s expected remediation of the material weakness in financial reporting controls.
- The effect of LTIP stock-based compensation, including the possibility of additional expense if currently non-probable milestones become probable or are achieved.